Description
- Early Hepatic fibrosis can be fully recovered, while the development of cirrhosis is not easy to recover. Therefore, early detection and active treatment of liver fibrosis to reverse or delay its development is very important to improve patients’ quality of life
- improve their prognosis and is also compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390.
Technical Specifications
| Model | YRA317 | YRA318 | YRA319 | YRA320 | YRA321 |
| Tested Parameter | PIIINP | CIV | LN | HA | CG |
| Analysis Mode | CLIA | ||||
| Package Specification | 50T/BOX, | ||||
| Platform | 100T/BOX,24T/BOX, 48T/BOX AP(Alkaline Phosphatase) | ||||
| Storage | 2-8°C | ||||
| Calibration | 2/6 Points | ||||
| Certification | CE, ISO13485,FSC | ||||
